-
Jun 13, 2022, 09:41 AM
by
As per Persistence Market Research’s latest industry analysis, the global medical wellness market was valued at over US$ 1 Tn in 2020, and is expected to exhibit a CAGR of 14.1% over the forecast period (2021-2031).
Full story
-
Jun 10, 2022, 09:03 AM
by
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.
Full story
-
Jun 10, 2022, 09:03 AM
by
mdgroup recognised as one of the UK's fastest-growing private companies
9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.
Full story
-
Jun 9, 2022, 09:13 AM
by
Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer
Full story
-
Jun 9, 2022, 09:13 AM
by
CAMBRIDGE, UK, 08 June 2022: Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and productivity of the drug discovery process.
Full story
-
Jun 9, 2022, 09:12 AM
by
Medcura, Inc., a commercial-stage life science and medical device company, has appointed James (Jim) Buck as Chief Executive Officer (CEO). A globally connected leader, Buck has been serving as Director at Medcura since 2018 and now fully steps into the CEO role with more than 25 years of highly relevant career experiences.
Full story
-
Jun 9, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Over the past two years, Stan Gloss, founding partner at BioTeam, has been sitting down with leaders in pharma and biotech for our Trends from the Trenches column and—more recently—the Trends from the Trenches podcast. They have been wide-ranging conversations covering everything from digital transformation at big pharma to All of Us and population genomics, data-driven cancer genomics to AI/ML models in drug discovery.
Full story
-
Jun 8, 2022, 09:18 AM
by
Full story
-
Jun 8, 2022, 09:18 AM
by
Full story
-
Jun 8, 2022, 09:18 AM
by
Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.
Full story
-
Jun 8, 2022, 09:18 AM
by
IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina.
Full story
-
Jun 8, 2022, 09:18 AM
by
Full story
-
Jun 8, 2022, 01:00 AM
by
User Not Found
Bio-IT World | The pioneering OneK1K study in Australia has identified an immune “fingerprint” of seven autoimmune disorders using single-cell RNA sequencing (scRNA-seq). The general framework, which combines the scRNA-seq data with genotype data to classify individual cells, can be applied to many different diseases.
Full story
-
Jun 7, 2022, 09:10 AM
by
Full story
-
Jun 7, 2022, 09:10 AM
by
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling. The SEQuoia Express Stranded RNA Library Prep Kit offers a cost-effective and automation-friendly solution to the current challenges in library generation. The kit enables researchers to construct robust libraries that capture mRNA and long noncoding RNA (>200 bp) transcripts for differential gene expression analysis and novel transcript discovery. Bio-Rad™ also provides a complementary and customized bioinformatics solution to streamline the full next-generation sequencing (NGS) workflow, from library preparation to data analysis.
Full story
-
Jun 7, 2022, 09:10 AM
by
DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value
Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.
Full story
-
Jun 7, 2022, 08:00 AM
by
User Not Found
Bio-IT World | Innovative Practices Award | AstraZeneca is using technology to speed and improve drug discovery at every step of the process, explained Anna Berg Asberg, global VP of R&D IT, last month in her presentation at the Bio-IT World Conference and Expo outlining AstraZeneca’s Bio-IT World Innovative Practices Award-winning project.
Full story
-
Jun 7, 2022, 01:00 AM
by
User Not Found
Bio-IT World | At the Bio-IT World Conference & Expo last month, several sessions explored ways AI is transforming oncology diagnosis, research, and care delivery. Speakers from the National Cancer Institute, Tempus Labs, The Ohio State University, IQVIA, Pangaea Data, University of Illinois Cancer Center, Stable Solutions and more discussed how far we’ve come, and where our next challenges lie.
Full story
-
Jun 6, 2022, 09:48 AM
by
Prayag Murawala, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, is leading the effort to establish the Mexican salamander, or axolotl, as a laboratory model for the study of regeneration. With the ability to regenerate almost any body part, the axolotl is nature’s champion of regeneration. The development of new tools to work with the axolotl is elevating it to the level of established research models and positioning the community of scientists who work with it for exponential growth. Many of the new tools developed for working with the axolotl, as well as those that are critically needed to expand the scope of axolotl research, are described by Murawala in two papers published in the June 2022 edition of the journal Developmental Dynamics.
Full story
-
Jun 6, 2022, 09:48 AM
by
Dotmatics, the leader in R&D scientific software adds Chief Legal Officer and Chief People Officer
Full story